Orna Therapeutics
Cambridge · Founded 2019
About Orna Therapeutics
Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way they treat disease. The company's proprietary platform combines novel technology to create oRNAs that drive protein expression with validated and unique delivery solutions. Orna Therapeutics was established in 2019 by Alex Wesselhoeft and Raffaella Squilloni in Cambridge, Massachusetts.
Company Facts
- Founded: 2019
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $321.0M
- Funding stage: M&A
- Last round: Series B (Aug 2022)
- Website: http://ornatx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/orna-therapeutics-60417 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.